SONAM PATEL M.D. NPI 1306230230

NPI Details

Sonam Patel, M.D. is a hematology and oncology internal medicine in Ames, IA with 10 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Sonam Patel, M.D. NPI is 1306230230. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: RUTGERS R W JOHNSON MEDICAL SCHOOL (CAM/NEW BRUNS/PISC)
Graduation Year:2015

The provider's business location address is:

1111 DUFF AVE
AMES, IA
ZIP 50010-745
Phone: (515) 239-4401

The NPI 1306230230 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, octreotide, depot form for intramuscular injection, 1 mg (HCPCS:J2353)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Magnesium level (HCPCS:83735)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Protein measurement, serum (HCPCS:84165)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Folic acid level, serum (HCPCS:82746)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Red blood count, automated test (HCPCS:85045)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Unclassified drugs (HCPCS:J3490)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Blood test, clotting time (HCPCS:85610)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Hospital discharge day management, more than 30 minutes (HCPCS:99239)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Total protein level, blood (HCPCS:84155)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Blood creatinine level (HCPCS:82565)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Reticulated (young) platelet measurement (HCPCS:85055)

The enumeration date for this NPI number is 3/28/2015 and was last updated on 8/2/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: